Application of artificial intelligence in breast cancer

doi:10.3877/cma.j.issn.1674-0807.2017.05.001

Abstract

Abstract:

Artificial intelligence refers to intelligence exhibited by man-made machines, with widespread social application. In medicine, artificial intelligence has been applied in medical imaging, in vitro diagnosis, surgical navigation, intelligent rehabilitation and big data on healthcare, and has played an important role in increasing the diagnosis rate of cancer, accelerating the development of new drugs, improving the diagnosis and treatment experience of patients and predicting the patients' prognosis. At present, the researches on artificial intelligence in breast cancer have made a lot of progress. We briefly summarized the application of artificial intelligence in imaging and pathological diagnosis of breast cancer and development of anti-cancer drugs.

Key words: Breast neoplasms, Artificial intelligence

Yan Xu, Baoquan Hu. Application of artificial intelligence in breast cancer[J]. Chinese Journal of Breast Disease(Electronic Edition), 2017, 11(05): 257-261.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhrxbzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-0807.2017.05.001

https://zhrxbzz.cma-cmc.com.cn/EN/Y2017/V11/I05/257

References 32

[1]	腾讯体育. 三连败收官! 柯洁再负AlphaGo 人机大战遭零封[EB/OL]. [2017-06-05]. http:/ /sports. qq. com/a/20170527/030772.htm.
[2]	No authors listed. R2 Technology[EB/OL]. [2017-06-05]. http:/ /www.r2tech.com/.
[3]	Beura S,Majhi B,Dash R, et al. Classification of mammogram using two-dimensional discrete orthonormal S-transform for breast cancer detection[J]. Healthc Technol Lett,2015,2(2):46-51.
[4]	Cheng HD,Shi XJ, Min R, et al. Approaches for automated detection and classification of masses in mammograms[J]. Pattern Recognit,2006,39(4):646-668.
[5]	Mahersia H, Boulehmi H, Hamrouni K. Development of intelligent systems based on Bayesian regularization network and neuro-fuzzy models for mass detection in mammograms: a comparative analysis[J].Comput Methods Programs Biomed,2016,126:46-62.
[6]	Parmeggiani D,Avenia N,Sanguinetti A,et al. Artificial intelligence against breast cancer (A. N. N. E. S-B. C.-Project)[J]. Ann Ital Chir,2012,83(1):1-5.
[7]	Patel TA,Puppala M,Ogunti RO,et al. Correlating mammographic and pathologic findings in clinical decision support using natural language processing and data mining methods[J]. Cancer, 2017,123(1):114-121.
[8]	No authors listed. Summary of safety and effectiveness [EB/OL].[2017-06-05]. https:/ /www. accessdata. fda. gov/cdrh_docs/pdf5/k050846.pdf.
[9]	Chabi ML,Borget I,Ardiles R, et al. Evaluation of the accuracy of a computer-aided diagnosis (CAD) system in breast ultrasound according to the radiologist's experience [J]. Acad Radiol, 2012,19 (3):311-319.
[10]	Wood C. Computer aided detection (CAD) for breast MRI[J].Technol Cancer Res Treat,2005,4(1):49-53.
[11]	Böttcher J,Renz DM,Zahm DM, et al. Response to neoadjuvant treatment of invasive ductal breast carcinomas including outcome evaluation: MRI analysis by an automatic CAD system in comparison to visual evaluation[J]. Acta Oncol,2014,53(6):759-768.
[12]	Song SE,Seo BK,Cho KR, et al. Computer-aided detection (CAD)system for breast MRI in assessment of local tumor extent,nodal status,and multifocality of invasive breast cancers: preliminary study[J].Cancer Imaging,2015,15:1.
[13]	Liu Y, Gadepalli K, Norouzi M, et al. Detecting cancer metastases on gigapixel pathology images[EB/OL]. [2017-06-05]. http:/ /www.datascienceassn. org/sites/default/files/Detecting%20Cancer%20 Metastases%20on%20Gigapixel%20Pathology%20Images.pdf.
[14]	Wang D, Khosla A, Gargeya R, et al. Deep learning for identifying metastatic breast cancer [EB/OL]. [2017-06-05]. http:/ /xueshu.baidu. com/s? wd = paperuri% 3A% 285cd6da92edd1ac337a8917 bfaf22ec46% 29&filter = sc _ long _ sign&tn = SE _ xueshusource _2kduw22v&sc _ vurl = http% 3A% 2F% 2Farxiv. org% 2Fpdf%2F1606.05718&ie=utf-8&sc_us=17802863608197391119&qq-pf-to=pcqq.c2c.
[15]	No authors listed. Our team transforming pathology together[ EB/OL].[2017-06-05]. https:/ /pathai.com/team.html.
[16]	Driessen H, Klink S. Philips and PathAI team up to improve breast cancer diagnosis using artificial intelligence technology in ‘big data'pathology research[EB/OL]. [2017-06-05]. http:/ /www. philips.com/a-w/about/news/archive/standard/news/press/2017/20170329-philips-and-pathai-team-up-to-improve-breast-cancer-diagnosis.html.
[17]	动脉网.解析DeepCare 的人工智能算法,92.5%的乳腺癌诊断准确率是如何实现的? [EB/OL]. [2017-06-05]. http:/ /vcbeat. net/35098.
[18]	Fiuzy M, Haddadnia J, Mollania N, et al. Introduction of a new diagnostic method for breast cancer based on fine needle aspiration(FNA) test data and combining intelligent systems[J]. Iran J Cancer Prev,2012,5(4):169-177.
[19]	Subbaiah RM,Dey P,Nijhawan R. Artificial neural network in breast lesions from fine-needle aspiration cytology smear [ J]. Diagn Cytopathol,2014,42(3):218-224.
[20]	No authors listed. Assisting pathologists in detecting cancer with deep learning[EB/OL]. [2017-06-05]. https:/ /research. googleblog. com/2017/03/assisting-pathologists-in-detecting.html.
[21]	Douglas I. Cancer drug development time halved thanks to artificial intelligence[EB/OL]. [2017-06-05]. http:/ /www.telegraph.co.uk/technology/news/11920393/Cancer-drug-development-time-halved-thanksto-artificial-intelligence.html.
[22]	Mullin E.Stopping breast cancer with help from AI[EB/OL]. [2017-06-05]. https:/ /www.technologyreview.com/s/602721/stopping-breastcancer-with-help-from-ai.
[23]	No authors listed.IBM Watson health and broad institute launch major research initiative to study why cancers become drug resistant[EB/OL]. [2017-06-05]. https:/ /www. broadinstitute. org/news/ibmwatson-health-and-broad-institute-launch-major-research-initiativestudy-why-cancers-become.
[24]	Memorial Sloan-Kettering Cancer Center. IBM Watson and quest diagnostics launch genomic sequencing service using data from MSK[EB/OL].[2017-06-05]. https:/ /www.mskcc.org/about/innovativecollaborations/watson-oncology.
[25]	IBM WatsonHealth. IBM Watson for genomics helps doctors give patients new hope[EB/OL]. [2017-06-05]. https:/ /www. ibm. com/watson/health/oncology-and-genomics/genomics/.
[26]	Somashekhar SP, Kumarc R, Rauthan A, et al. Abstract S6-07:Double blinded validation study to assess performance of IBM artificial intelligence platform, Watson for oncology in comparison with Manipal multidisciplinary tumour board - First study of 638 breast cancer cases[J]. Cancer Res,2017,77(4): S16-S6-07.
[27]	杭州认知网络科技有限公司. 21 家中国医院将应用IBM Watson 肿瘤解决方案(IBM Watson for Oncology)助力医师提供个性化癌症诊疗[EB/OL].[2017-06-05]. http:/ /www. cognitivecare. cn/archives/210,2016-08-12.
[28]	浙江省中医院新闻中心.携手成立沃森联合会诊中心,共同打造现代智慧医院——全国首家智能诊疗会诊中心落户我院[EB/OL].[2017-06-05]. http:/ /www. zjhtcm. com/Art/Art_2/Art_2_2376.aspx.
[29]	Kim W,Kim KS,Lee JE,et al. Development of novel breast cancer recurrence prediction model using support vector machine[J]. J Breast Cancer,2012,15(2):230-238.
[30]	Kempowsky-Hamon T,Valle C,Lacroix-Triki M,et al. Fuzzy logic selection as a new reliable tool to identify molecular grade signatures in breast cancer--the INNODIAG study[J]. BMC Med Genomics, 2015,8:3.
[31]	No authors listed.Innovative, personal early breast wellness screening[EB/OL].[2017-06-05]. http:/ /cyrcadiahealth.com/.
[32]	中华人民共和国国务院.2017 年政府工作报告[EB/OL]. [2017-06-05]. http:/ /www. gov. cn/premier/2017-03/16/content_5177940.htm.

Please choose a citation manager

Content to export